Windham Venture Partners

@windhamvp

July 17, 2018

Personal Genome Diagnostics’ PGDx elio™ plasma resolve Receives Breakthrough Device Designation from FDA

— PGDx Developing In-Vitro Diagnostic Test that Detects MSI Status in Plasma as an Aid in Selecting Cancer Patients For Certain Immunotherapies BALTIMORE, MD, July 17, 2018 – Personal Genome … Continued

July 16, 2018

Cartiva Announces Presentation of Long-Term Clinical Data on Treating Big Toe Arthritis with Cartiva Synthetic Cartilage Implant

ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., (Company) a medical device company focused on the treatment of osteoarthritis of the extremities, announced today the presentation of five-year follow up results from its pivotal … Continued

Archives

© 2024 Windham Venture Partners 500 Fifth Avenue, Suite 3600, NY, NY 10110